FR3086865B1 - Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie - Google Patents

Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie Download PDF

Info

Publication number
FR3086865B1
FR3086865B1 FR1859207A FR1859207A FR3086865B1 FR 3086865 B1 FR3086865 B1 FR 3086865B1 FR 1859207 A FR1859207 A FR 1859207A FR 1859207 A FR1859207 A FR 1859207A FR 3086865 B1 FR3086865 B1 FR 3086865B1
Authority
FR
France
Prior art keywords
myopia
progression
inhibition
prevention
limitation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1859207A
Other languages
English (en)
Other versions
FR3086865A1 (fr
Inventor
Matthieu Leconte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1859207A priority Critical patent/FR3086865B1/fr
Publication of FR3086865A1 publication Critical patent/FR3086865A1/fr
Application granted granted Critical
Publication of FR3086865B1 publication Critical patent/FR3086865B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention porte sur une préparation ophtalmique comprenant de l'atropine et de l'acide hyaluronique.
FR1859207A 2018-10-04 2018-10-04 Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie Active FR3086865B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1859207A FR3086865B1 (fr) 2018-10-04 2018-10-04 Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1859207A FR3086865B1 (fr) 2018-10-04 2018-10-04 Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie

Publications (2)

Publication Number Publication Date
FR3086865A1 FR3086865A1 (fr) 2020-04-10
FR3086865B1 true FR3086865B1 (fr) 2023-04-28

Family

ID=65494326

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1859207A Active FR3086865B1 (fr) 2018-10-04 2018-10-04 Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie

Country Status (1)

Country Link
FR (1) FR3086865B1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US10413506B2 (en) * 2010-04-03 2019-09-17 Praful Doshi Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
CN107456440A (zh) * 2017-08-07 2017-12-12 杭州赫尔斯科技有限公司 一种低浓度阿托品类药物滴眼液及其制备方法
CN107982212A (zh) * 2017-11-28 2018-05-04 杭州赫尔斯科技有限公司 一种阿托品类药物缓释滴眼液及其制备方法
CN108338969A (zh) * 2018-02-08 2018-07-31 胡敏 一种低浓度托烷类药物滴眼液及其制备方法

Also Published As

Publication number Publication date
FR3086865A1 (fr) 2020-04-10

Similar Documents

Publication Publication Date Title
MA53937A (fr) Compositions comprenant des souches bactériennes
MA51530B1 (fr) Composés cycliques fondus
MA49279A (fr) Compositions d'anticorps optimisées pour le traitement de troubles oculaires
MA40306A1 (fr) Méthodes et formulations pour le traitement de pathologies oculaires vasculaires
EP3830139A4 (fr) Fucanes hautement purifiés pour le traitement d'adhérences fibreuses
EP3747449A4 (fr) Composition pharmaceutique comprenant des mitochondries isolées pour la prévention ou le traitement de la polyarthrite rhumatoïde
MA51520A (fr) Dérivés de 1,3,4,5-tétrahydro-2h-pyrido[4,3-b]indole pour le traitement, le soulagement ou la prévention de troubles associés à des agrégats de tau comme la maladie d'alzheimer
MA45598B1 (fr) Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda
EA201992688A1 (ru) Средства, пути применения и способы лечения
MA54522A (fr) Composition pharmaceutique pour le traitement de l'hypertension artérielle pulmonaire
EP3900714A4 (fr) Agent contenant du 4-phénylbutyrate, pour la prévention ou le traitement de la presbytie
MA55490A (fr) Mutéine de lipocaline pour le traitement de l'asthme
EP3952881A4 (fr) Compositions et procédés pour le traitement d'inconfort des lentilles de contact
MA38369B1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
EP3936124A4 (fr) Composition pharmaceutique pour la prévention ou le traitement de maladies neurologiques
MA54511B1 (fr) Composition ophtalmique nutraceutique pour le traitement de pathologies retiniennes a composante neovasculaire
EP3785718A4 (fr) Composition pharmaceutique pour la prévention ou le traitement d'une maladie infectieuse de flavivirus
EP3996729C0 (fr) Composition pour la prévention ou le traitement de la dépression ou de l'anxiété
MA56998B1 (fr) Traitement de symptômes induits par le cycle menstruel
CA3156671A1 (fr) Compositions nutritionnelles pour la gestion de l'hyponatremie
FR3086865B1 (fr) Preparation ophtalmique et lentille d'orthokeratologie pour l'inhibition, la prevention et/ou la limitation de la progression de la myopie
EP3952857A4 (fr) Compositions et méthodes pour le traitement de l'homocystinurie et d'autres pathologies
EP4230652A4 (fr) Anticorps anti-oscar pour la prévention ou le traitement de l'arthrose
EP3826633A4 (fr) Compositions pour le traitement de l'hypertension
MA44660B1 (fr) (+) -azasetron pour son utilisation dans le traitement des troubles de l'oreille

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLSC Publication of the preliminary search report

Effective date: 20200410

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8